Pneumology - Original Articles
16 September 2025

Cross-sectional study of pulmonary hypertension among patients with chronic obstructive pulmonary disease

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
152
Views
71
Downloads

Authors

The prevalence graph of chronic obstructive pulmonary disease (COPD) in India is escalating significantly. Pulmonary hypertension (PH) is one of the most important complications of COPD, leading to worsened clinical progression. Various studies have predicted the correlation of PH with the degree of airflow obstruction in COPD, but the association between PH and the ABCD stage of COPD, as per the recent Global Initiative for Chronic Lung Disease (GOLD) criteria, is still ambiguous and underexplored. Thus, we aim to correlate the association of PH with the updated staging of COPD. This prospective study followed 100 COPD patients diagnosed based on spirometry and clinical symptoms over a 1-year period. The severity and staging of COPD were determined according to GOLD classification criteria. Screening two-dimensional echocardiography was performed to assess PH. The association between PH and COPD staging was analyzed. Among the 100 subjects with COPD, the mean age was 60.6±7.8 years, and 70% were male. Based on disease staging, 23 patients (23%) were classified as stage A, 25 (25%) as stage B, 13 (13%) as stage C, and 39 (39%) as stage D. PH was present in 72 patients: 25 (25%) had mild PH, 26 (26%) had moderate PH, and 21 (21%) had severe PH. A significant association was observed between the stages of COPD and the severity of PH. PH is a major complication in COPD, leading to poor prognosis. Therefore, incorporating early cardiac screening in all COPD patients may assist in assessing prognosis, morbidity, and mortality.

Altmetrics

Downloads

Download data is not yet available.

Citations

Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the prevention, diagnosis and management of COPD: 2021 Report. 2021. Available from: https://share.google/oNyoB3u4LY7zQwHwi.
World Health Organization. Chronic obstructive pulmonary disease (COPD). 2024. Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general population. Am J Respir Crit Care Med 2012;186:975-81. DOI: https://doi.org/10.1164/rccm.201207-1299OC
Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Am J Respir Crit Care Med 2017;195:557-82. DOI: https://doi.org/10.1164/rccm.201701-0218PP
Johannessen A, Nilsen RM, Storebø M, et al. Comparison of 2011 and 2007 Global Initiative for Chronic Obstructive Lung Disease guidelines for predicting mortality and hospitalization. Am J Respir Crit Care Med 2013;188:51-9. DOI: https://doi.org/10.1164/rccm.201212-2276OC
Bossone E, D’Andrea A, D’Alto M, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 2013;26:1-14. DOI: https://doi.org/10.1016/j.echo.2012.10.009
Daniels LB, Krummen DE, Blanchard DG. Echocardiography in pulmonary vascular disease. Cardiol Clin 2004;22:383-99. DOI: https://doi.org/10.1016/j.ccl.2004.04.007
Yock PG, Popp RL. Noninvasive estimation of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70:657-62. DOI: https://doi.org/10.1161/01.CIR.70.4.657
Gupta K, Agrawal RK, Srivastav AB, et al. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India 2011;28:105-9. DOI: https://doi.org/10.4103/0970-2113.80321
Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713. DOI: https://doi.org/10.1016/j.echo.2010.05.010
Chemla D, Castelain V, Humbert M, et al. New formula for predicting mean pulmonary artery pressure using systolic pulmonary artery pressure. Chest 2004;126:1313-7. DOI: https://doi.org/10.1378/chest.126.4.1313
Gupta KK, Roy B, Chaudhary SC, et al. Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life. J Family Med Prim Care 2018;7:53-7. DOI: https://doi.org/10.4103/jfmpc.jfmpc_18_17
Alexopoulos EC, Malli F, Gourgoulianis KI. Frequency and risk factors of COPD exacerbations and hospitalizations: a nationwide study in Greece (GOLDEN study). Int J Chron Obstruct Pulmon Dis 2015;10:2665-74. DOI: https://doi.org/10.2147/COPD.S91392
Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J 2008;32:1371-85. DOI: https://doi.org/10.1183/09031936.00015608

Ethics approval

The study was approved by the Institutional Ethical Committee(177/MC/EC/2020 dated on 2/2/2021).

How to Cite



“Cross-Sectional Study of Pulmonary Hypertension Among Patients With Chronic Obstructive Pulmonary Disease”. 2025. Monaldi Archives for Chest Disease, September. https://doi.org/10.4081/monaldi.2025.3534.